Skip to main content
. 2021 Mar 11;18:E22. doi: 10.5888/pcd18.200365

Table 1. Study Characteristics for Articles Reporting on Glycated Hemoglobin A1c (HbA1c) Performance Among African Descent Populations Living in the United States, 2010–2019.

Study First Author (Year); Study N; Sex Race/Ethnicitya (%) Age, y Location Study Design HbA1c Laboratory Analysis Method
African American
1 Bleyer (2010) (26) N = 885; 43.2% male and 56.8% female 43.5% African American; 56.5% White ≥18 Winston-Salem, North Carolina Clinical; retrospective study Cation-exchange column chromatography on an automated HPLC instrument (Variant II Turbo, Bio-Rad Laboratories).
2 Carson (2016); CARDIA study (27) N = 2,692; 45.5% male and 54.5% female 44% African American; 56% White Mean (SD): 45.3 (3.6) Minneapolis, Minnesota; Chicago, Illinois; Birmingham, Alabama; Oakland, California Database analysis Whole blood aliquot by ion-exchange HPLC using a Tosoh G7 (Tosoh Bioscience).
3 Cutrona (2015); FACHS (28) N = 312; 100% female 100% African American 26–92; Mean (SD): 47 (7) Ames, Iowa; Athens, Georgia Database analysis Whole blood aliquot by turbidimetric immunoinhibition
(University of Iowa Clinical Pathology Laboratories).
4 Getaneh (2011); NHANES III and DIAMOND Study (29) N = 16,056b; 48.1% male and 51.9% female 4.3% Dominican; 28.9% Hispanic; 26.9% African American; 39.9% White Range of mean ages: 38.2–63.3 NHANES III: United States.
DIAMOND: New York, New York
Database analysis Diamat HPLC from Bio-Rad Laboratories.c
5 Hivert (2019); DPP (30) N = 2,658; 33% male and 67% female 55.5% White; 20.2% African American; 17.0% Hispanic; 4.4% Asian; 2.9% American Indian ≥25; Mean (SD): 50.7 (10.7) 27 US clinical centersd Clinical Ion-exchange HPLC instrument (Variant; Bio-Rad Laboratories).
6 Homko (2012) (31) N = 83; 7.2% male and 92.8% female 100% African American Mean (SD): 53 (10.4) Philadelphia, Pennsylvania Clinical CDC-approved automated point-of-care analyzer (DCA 2000, Bayer Corporation): monoclonal antibody recognizes glycated N terminus of β chain of hemoglobin.
7 Meigs (2014); BACH Prediabetes Study (32) N = 1,387; 37.4% male and 62.6% female 27.3% African American; 29.6% Hispanic; 43.0% White 34–87 Boston, Massachusetts Clinical Tina-Quant HbA1c generation 2 assay with analytic measurement range of 3.4%–18% (Quest Diagnostics).
Afro-Caribbean
8 Exebio (2012) (33) N = 128e 100% Haitian American ≥35 Miami, Florida Clinical Whole blood with close tube sampling, in duplicate (coefficient of variation <1.7%), with Roche Tina Quant Second Generation A1c immunoassay method of Laboratory Corporation of America.
African
9 Briker (2019); The AIA Study (34) N = 430; 65% male and 35% female 100% African immigrants in the United States Mean (SD): 38 (10) Bethesda, Maryland Clinical NGSP-certified instruments: BioRad Laboratories Classic Variant (n = 32), Bio-Rad Laboratories Variant II (n = 158), and BioRad Laboratories D10 (n = 240) used sequentially by the NIH Clinical Center for HPLC.
10 Sumner 1 (2015); The AIA Study (35) N = 216; 68% male and 32% female 100% African immigrants in the United States 20–64; mean (SD): 37 (10) Bethesda, Maryland Clinical NGSP-certified instruments: Classic Variant, Variant II, and D10 for HPLC (Bio-Rad Laboratories). Whole blood samples in 90 participants analyzed by boronate affinity chromatography method on NGSP-certified Premier Hb9210 analyzer (Trinity Biotech).
11 Sumner 2 (2016); The AIA Study (36) N = 236; 69% male and 31% female 100% African immigrants in the United States 20–64; Mean (SD): 39 (10) Bethesda, Maryland Clinical NGSP-certified instruments: Variant II and D10 for HPLC (Bio-Rad Laboratories).
12 Sumner 3 (2016); The AIA Study (37) N = 217; 69% male and 31% female 100% African immigrants in the United States 20–64; Mean (SD): 39 (10) Bethesda, Maryland Clinical NGSP-certified instruments: Variant II and D10 for HPLC (Bio-Rad Laboratories).

Abbreviations: AIA, Africans in America; BACH, Boston Area Community Health; CARDIA, Coronary Artery Risk Development in Young Adults; CDC, Centers for Disease Control and Prevention; DIAMOND, Diabetes Among Dominicans and Other Minorities in Northern Manhattan; DPP, Diabetes Prevention Program; FACHS, Family and Community Health Study; HPLC, high performance liquid chromatography; NHANES III, the third National Health and Nutrition Examination Survey; NIH, National Institutes of Health; NGSP, National Glycohemoglobin Standardization Program.

a

For all studies, White refers to Caucasian, Non-Hispanic White, and/or European White.

b

Participant data extracted from Table 1, “Sociodemographic Characteristics of Dominicans and the Third National Health and Nutrition Examination Survey Populations, Stratified by Hemoglobin A1c-Based Diabetes Diagnosis” (29).

c

Laboratory analysis data extracted from “Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988–94. Series 1: Programs and Collection Procedures” (38).

d

Location data extracted from “The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes” (39).

e

Breakdown for sex/gender not available.